行情

PEN

PEN

Penumbra
NYSE

实时行情|Nasdaq Last Sale

166.76
+1.92
+1.16%
盘后: 166.76 0 0.00% 16:00 11/15 EST
开盘
165.66
昨收
164.84
最高
168.25
最低
165.66
成交量
58.79万
成交额
--
52周最高
185.70
52周最低
110.84
市值
58.22亿
市盈率(TTM)
135.84
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

PEN 新闻

  • 传John Legere不会成为WeWork的下任CEO
  • 新浪财经综合.2小时前
  • 日本人引以为傲的24小时营业 正被便利店巨头们放弃
  • 新浪财经综合.2小时前
  • Fitbit已被谷歌收入囊中 下一个被收购的将是GoPro?
  • 新浪财经综合.3小时前
  • 美国强生公司因阿片类药物案罚款减少股价上涨约3%
  • 新浪美股.3小时前

更多

所属板块

医疗设备、用品及经销
+1.04%
医疗设备和用品
+1.69%

热门股票

名称
价格
涨跌幅

PEN 简况

Penumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. It focuses on developing, manufacturing and marketing products for use by specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular surgeons. Its neuro products include Neurovascular Access, Neuro Thrombectomy (Ischemic Stroke), Neurovascular Embolization (Brain Aneurysms) and Neurosurgical Tools (Hemorrhagic Stroke). Its peripheral vascular products include Peripheral Vascular Embolization and Peripheral Thrombectomy.
展开

Webull提供Penumbra Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。